Next Article in Journal
Nanosecond T-Jump Experiment in Poly(glutamic acid): A Circular Dichroism Study
Previous Article in Journal
A Novel LMP1 Antibody Synergizes with Mitomycin C to Inhibit Nasopharyngeal Carcinoma Growth in Vivo Through Inducing Apoptosis and Downregulating Vascular Endothelial Growth Factor
Article Menu

Export Article

Open AccessReview
Int. J. Mol. Sci. 2012, 13(2), 2219-2238; doi:10.3390/ijms13022219

Alpha7 Nicotinic Acetylcholine Receptor Is a Target in Pharmacology and Toxicology

Faculty of Military Health Sciences, University of Defence, Trebesska 1575, 50001 Hradec Kralove, Czech Republic
Received: 16 January 2012 / Revised: 26 January 2012 / Accepted: 14 February 2012 / Published: 17 February 2012
View Full-Text   |   Download PDF [334 KB, uploaded 19 June 2014]   |  

Abstract

Alpha7 nicotinic acetylcholine receptor (α7 nAChR) is an important part of the cholinergic nerve system in the brain. Moreover, it is associated with a cholinergic anti-inflammatory pathway in the termination of the parasympathetic nervous system. Antagonists of α7 nAChR are a wide group represented by conotoxin and bungarotoxin. Even Alzheimer’s disease drug memantine acting as an antagonist in its side pathway belongs in this group. Agonists of α7 nAChR are suitable for treatment of multiple cognitive dysfunctions such as Alzheimer’s disease or schizophrenia. Inflammation or even sepsis can be ameliorated by the agonistic acting compounds. Preparations RG3487, SEN34625/WYE-103914, SEN12333, ABT-107, Clozapine, GTS-21, CNI-1493, and AR-R17779 are representative examples of the novel compounds with affinity toward the α7 nAChR. Pharmacological, toxicological, and medicinal significance of α7 nAChR are discussed throughout this paper. View Full-Text
Keywords: inflammation; cholinergic anti-inflammatory pathway; schizophrenia; Alzheimer’s disease; cognitive disorder; agonist; antagonist inflammation; cholinergic anti-inflammatory pathway; schizophrenia; Alzheimer’s disease; cognitive disorder; agonist; antagonist
This is an open access article distributed under the Creative Commons Attribution License (CC BY 3.0).

Scifeed alert for new publications

Never miss any articles matching your research from any publisher
  • Get alerts for new papers matching your research
  • Find out the new papers from selected authors
  • Updated daily for 49'000+ journals and 6000+ publishers
  • Define your Scifeed now

SciFeed Share & Cite This Article

MDPI and ACS Style

Pohanka, M. Alpha7 Nicotinic Acetylcholine Receptor Is a Target in Pharmacology and Toxicology. Int. J. Mol. Sci. 2012, 13, 2219-2238.

Show more citation formats Show less citations formats

Related Articles

Article Metrics

Article Access Statistics

1

Comments

[Return to top]
Int. J. Mol. Sci. EISSN 1422-0067 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert
Back to Top